Gα-13 induces CXC motif chemokine ligand 5 expression in prostate cancer cells by transactivating NF-κB

Abstract

Edited by Henrik G. Dohlman GNA13, the ␣ subunit of a heterotrimeric G protein, mediates signaling through G-protein-coupled receptors (GPCRs). GNA13 is up-regulated in many solid tumors, including prostate cancer, where it contributes to tumor initiation, drug resistance, and metastasis. To better understand how GNA13 contributes to tumorigenesis and tumor progression, we compared the entire transcriptome of PC3 prostate cancer cells with those cells in which GNA13 expression had been silenced. This analysis revealed that GNA13 levels affected multiple CXC-family chemokines. Further investigation in three different prostate cancer cell lines singled out pro-tumorigenic CXC motif chemokine ligand 5 (CXCL5) as a target of GNA13 signaling. Elevation of GNA13 levels consistently induced CXCL5 RNA and protein expression in all three cell lines. Analysis of the CXCL5 promoter revealed that the ؊505/؉62 region was both highly active and influenced by GNA13, and a single NF-B site within this region of the promoter was critical for GNA13-dependent promoter activity. ChIP experiments revealed that, upon induction of GNA13 expression, occupancy at the CXCL5 promoter was significantly enriched for the p65 component of NF-B. GNA13 knockdown suppressed both p65 phosphorylation and the activity of a specific NF-B reporter, and p65 silencing impaired the GNA13-enhanced expression of CXCL5. Finally, blockade of Rho GTPase activity eliminated the impact of GNA13 on NF-B transcriptional activity and CXCL5 expression. Together, these findings suggest that GNA13 drives CXCL5 expression by transactivating NF-B in a Rho-dependent manner in prostate cancer cells. Prostate cancer is the second most prevalent cancer in males and is currently ranked the 5th leading cause of cancer deaths worldwide (1). The major reasons for death from prostate cancer are metastasis, drug resistance, and tumor relapse (2). As such, identifying the cellular mechanisms that contribute to prostate tumorigenesis and cancer progression would aid in the development of novel therapeutics to improve outcomes (3). Although previous studies on prostate cancer signaling have mostly focused on androgen hormone-signaling pathways, recent investigations have implicated G-protein-coupled receptors (GPCRs) 3 and their downstream signaling molecules in prostate cancer initiation and progression (3, 4). GPCRs are the largest and most diverse group of integral membrane proteins in eukaryotes. These proteins mediate cellular responses to a wide variety of ligands and are also important for numerous physiological functions (5). GPCRs are coupled to heterotrimeric G proteins that are made up of G ␣ , G ␤ , and G ␥ subunits, from which the G ␣ class can be further categorized into the G s , G q , G i , and G 12 subfamilies (6). Heterotrimeric G proteins function as molecular switches; ligand binding to the GPCR triggers a conformational change in the transmembrane region of the receptor, resulting in a GDP-GTP exchange on the G ␣ subunit and its subsequent dissociation from the...

Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis

“…MAZ upregulates Ras expression and then activates NF-κB through the RalGEF/Ral/NF-κB cascade and finally activates the EMT [97,99]. In addition, NF-κB is involved in the heterotrimer G-protein signaling network, which mediates cell adhesion signals through guanine nucleotide-binding protein subunit α-15 (GNA15), and Rho, which promotes CXCL5 expression [100,101]. Another important branch of the Ras-signaling network is the Ras/PI3K/Akt signaling cascade, which transduces signals from growth factor receptors and promotes PCa metastasis, as described in the previous section [102].…”

HDAC3 regulates senescence and lineage specificity in non-small cell lung cancer

“…2G). Importantly, the p65 NF-κB binding elements of each of these genes has been fully annotated and all lie within 100bp of the TSS (29–32). Notably, we did not observe differences in histone acetylation at the HDAC3-bound genomic regions associated with upregulated gene expression (Fig.…”

“…The enzymatic activity of HDAC3 is dependent on its interaction with NCoR or SMRT. Nuclear receptors function as signal-dependent transcription factors that integrate and deliver developmental, hormonal, environmental and nutrient cues to the genome, thereby acting as genetic switches of gene transcription [32][33][34][35] . In the classical model of nuclear receptor function, ligand binding elicits an allosteric change in the structure of the nuclear receptor, which facilitates differential recruitment of co-activators or co-repressors 36,37 Co-activators with HAT activity bind to ligand-bound nuclear receptors, whereas co-repressors bind ligand-free nuclear receptors to directly mediate gene repression or less commonly to indirectly mediate gene activation (FIG.…”

TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis

“…Mounting evidence suggests that the NF-κB signaling pathway is involved in the progression of various human tumors, including those of ovarian cancer (43), prostate cancer (44), cervical cancer (45), as well as head and neck cancer (46). A recent study demonstrated that TRIM22 negatively regulates the tumor necrosis factor receptor-associated factor 6 (TRAF6)-stimulated NF-κB pathway by binding to the TRIM22 N-terminal RING domain (47).…”